DA-2803

· Dong-A ST Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DA-2803, covering 2024-10-23 to 2024-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients [Phase 4]